Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Fagron NV: Fagron reaches settlement in principle with US Department of Justice
By: Nasdaq / GlobeNewswire - 26 Jun 2019Back to overview list

Regulated information - Inside information
Nazareth (Belgium)/Rotterdam (The Netherlands), 26 June 2019 - 15:00 CEST

Fagron reaches settlement in principle with US Department of Justice

Fagron announced today that it has reached a settlement in principle with the US Department of Justice regarding the previously announced civil investigation in the context of the sector-wide investigation into the pricing of pharmaceutical products. The final, legally binding, settlement between the US Department of Justice and Fagron is expected to be formalized in the second semester of 2019.

The settlement in principle consists of a payment by Fagron of US$ 22.3 million (€ 19.6 million). In anticipation of the conclusion of a definitive settlement, Fagron takes, in addition to the current provision of US$ 8.4 million, an additional provision of US$ 13.9 million, which will be included in the results of the first semester of 2019.

In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.

For more information
Constantijn van Rietschoten
Chief Communications Officer
Tel. +31 6 53 69 15 85
constantijn.van.rietschoten@fagron.com

Please open the link below for the press release:

Attachment

Copyright 2019 Nasdaq / GlobeNewswire Back to overview list
to the top ↑